Predictive Value of TB-symptom Screen in HIV-infected and HIV-uninfected Pregnant Women in Pune, India

Post Date: 
2014-10-28
   |   
Countries: 
   |   
Clinical Sites: 
Summary: 
This study was terminated July 17, 2017.
 
This is a cross sectional observational study will be conducted at BJGMC to establish what the predictive value of the WHO TB symptom screen is in pregnant women in India. We hypothesize that the WHO TB symptom screen will have a higher positive predictive value (PPV) in HIV-seronegative pregnant women as compared to HIV-infected pregnant women. The primary objective is to determine and compare the positive predictive value of the WHO TB symptom screen in both HIV seropositive and seronegative pregnant women.
 
Collaborators: 

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

Weill Cornell School of Medicine, New York, NY